RxDoctor Payments Data

Alfred Poindexter

Gynecology · Houston, TXNPI 1326129362

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,688 of the $4,727 with a category attached, or 99.2%. AbbVie accounts for 99.2% of it on its own, with 2 other manufacturers making up the rest.

$4,727in general payments, 2019–2025

Across 5 payments — averaging $945.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Ferring International Pharmascience Center US$26
  • Merck$14
$1,602,453in research payments, 2019–2025

Across 439 payments — averaging $3650.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$699K
  • Sebela Pharmaceuticals Inc.$256K
  • Bayer$197K
  • Sebela Women's Health Inc.$153K
  • Pfizer$67K
  • Sumitomo Pharma America, Inc.$64K
  • plus $167K from 7 others

What the payments were for

  • Consulting fees$4,68899%
  • Food & beverage$401%

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,727 in reported general payments places this provider in the 85th percentile of 161 gynecology providers in Texas.

See all gynecology providers in Texas

Other gynecology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →